Authors:
Bezard, E
Ravenscroft, P
Gross, CE
Crossman, AR
Brotchie, JM
Citation: E. Bezard et al., Upregulation of striatal preproenkephalin gene expression occurs before the appearance of parkinsonian signs in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys, NEUROBIOL D, 8(2), 2001, pp. 343-350
Authors:
Bezard, E
Dovero, S
Prunier, C
Ravenscroft, P
Chalon, S
Guilloteau, D
Crossman, AR
Bioulac, B
Brotchie, JM
Gross, CE
Citation: E. Bezard et al., Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned macaque model of Parkinson's disease, J NEUROSC, 21(17), 2001, pp. 6853-6861
Authors:
McArthur, JM
Ravenscroft, P
Safiulla, S
Thirlwall, MF
Citation: Jm. Mcarthur et al., Arsenic in groundwater: Testing pollution mechanisms for sedimentary aquifers in Bangladesh, WATER RES R, 37(1), 2001, pp. 109-117
Authors:
Keeling, SE
Albinson, FD
Ayres, BE
Butchers, PR
Chambers, CL
Cherry, PC
Ellis, F
Ewan, GB
Gregson, M
Knight, J
Mills, K
Ravenscroft, P
Reynolds, LH
Sanjar, S
Sheehan, MJ
Citation: Se. Keeling et al., The discovery and synthesis of highly potent, A(2a) receptor agonists, BIOORG MED, 10(4), 2000, pp. 403-406
Citation: P. Ravenscroft et J. Schneider, Bedside perspectives on the use of opioids: Transferring results of clinical research into practice, CLIN EXP PH, 27(7), 2000, pp. 529-532